Utama › Kanser Pundi Kencing › North Carolina › Durham
Kajian klinikal Kanser Pundi Kencing di Durham, NC
20 kajian untuk Kanser Pundi Kencing sedang mencari peserta di lokasi dalam dan sekitar Durham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Durham VA Medical Center, Durham
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Mengambil pesertaFasa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Mengambil pesertaFasa 1/2
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- Duke University Medical Center, Durham
- dan 1 lagi
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Mengambil pesertaFasa 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
- Research Site, Durham
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Mengambil pesertaFasa 1
- Duke University Medical Center - Duke Cancer Center, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- UNC- Chapel Hill, Chapel Hill · 10 mi jauh
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Mengambil pesertaFasa 2
- University of North Carolina, Chapel Hill · 10 mi jauh
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Mengambil pesertaFasa 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 mi jauh
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Mengambil pesertaFasa 2/3
- Research Site, Chapel Hill · 10 mi jauh
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Mengambil pesertaFasa 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Mengambil pesertaFasa 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · 10 mi jauh
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Mengambil pesertaKajian pemerhatian
- University of North Carolina, Chapel Hill · 10 mi jauh
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Mengambil pesertaFasa 2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauh
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · 10 mi jauh
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Mengambil peserta
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi jauh
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
Mengambil pesertaKajian pemerhatian
- Duke University, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Mengambil pesertaFasa 1
- Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi jauh
Kajian Kanser Pundi Kencing di bandar lain
- New York City, NY35 kajian
- Nashville, TN31 kajian
- Houston, TX31 kajian
- Dallas, TX27 kajian
- Boston, MA26 kajian
- Washington, DC26 kajian
- Los Angeles, CA24 kajian
- Baltimore, MD24 kajian
- St. Louis, MO22 kajian
- Philadelphia, PA21 kajian
- Seattle, WA21 kajian
- Edison, NJ21 kajian
Kajian lain di Durham
- Kanser Payudara63 kajian
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil39 kajian
- Mieloma Pelbagai37 kajian
- Kanser Metastatik33 kajian
- Leukemia Mieloid Akut33 kajian
- Kanser Paru-paru32 kajian
- Kanser Prostat32 kajian
- Kanser Kolorektal28 kajian
- Leukemia Limfositik Kronik27 kajian
- Kanser Ovari27 kajian
- Kegagalan Jantung26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.